rs10514611
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002163.4(IRF8):c.*354C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 279,678 control chromosomes in the GnomAD database, including 6,989 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 3935 hom., cov: 33)
Exomes 𝑓: 0.21 ( 3054 hom. )
Consequence
IRF8
NM_002163.4 3_prime_UTR
NM_002163.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.506
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-85921636-C-T is Benign according to our data. Variant chr16-85921636-C-T is described in ClinVar as [Benign]. Clinvar id is 1168174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF8 | NM_002163.4 | c.*354C>T | 3_prime_UTR_variant | 9/9 | ENST00000268638.10 | NP_002154.1 | ||
IRF8 | NM_001363907.1 | c.*354C>T | 3_prime_UTR_variant | 9/9 | NP_001350836.1 | |||
IRF8 | NM_001363908.1 | c.*354C>T | 3_prime_UTR_variant | 7/7 | NP_001350837.1 | |||
IRF8 | XM_047434052.1 | c.*354C>T | 3_prime_UTR_variant | 10/10 | XP_047290008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF8 | ENST00000268638.10 | c.*354C>T | 3_prime_UTR_variant | 9/9 | 1 | NM_002163.4 | ENSP00000268638 | P1 |
Frequencies
GnomAD3 genomes AF: 0.225 AC: 34230AN: 152012Hom.: 3929 Cov.: 33
GnomAD3 genomes
AF:
AC:
34230
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.212 AC: 27001AN: 127548Hom.: 3054 Cov.: 0 AF XY: 0.205 AC XY: 13747AN XY: 67134
GnomAD4 exome
AF:
AC:
27001
AN:
127548
Hom.:
Cov.:
0
AF XY:
AC XY:
13747
AN XY:
67134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.225 AC: 34268AN: 152130Hom.: 3935 Cov.: 33 AF XY: 0.226 AC XY: 16770AN XY: 74366
GnomAD4 genome
AF:
AC:
34268
AN:
152130
Hom.:
Cov.:
33
AF XY:
AC XY:
16770
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
612
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4016741:Immunodeficiency 32B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at